Impassioned Team

Delphinus is comprised of passionate individuals dedicated to developing and advancing the next generation of breast imaging technology. Our team is introducing a unique and sophisticated approach to detect breast cancer, driven forward by the thousands of women each year, who are told they have breast cancer. Our leadership is proud to work side-by-side with this inspiring team, who are committed to improving the future of breast imaging for all women.

Mark J. Forchette

President and Chief Executive Officer

Mark is an accomplished medical technology executive with demonstrated success transforming industries and driving breakthrough technologies to market leadership. Prior to joining Delphinus, Mark was president and chief executive officer of OptiMedica Corporation, an ophthalmic medical device company. He led the start-up venture through development and growth, successfully completed multiple rounds of financing, and oversaw the company’s acquisition by Abbott Laboratories in 2013. He began his career in the medical technology industry as a sales representative at Greishaber and Company, Inc., where he ultimately became vice president of U.S. sales and marketing and led the company through its acquisition by Alcon. During his tenure at Alcon, he steered the tactical integration of Grieshaber and advanced to Vice President of vitreoretinal sales and global marketing. Mark has a bachelor’s degree in marketing from Auburn University and completed the Harvard Program for Management Development. He is currently on the Dean’s Advisory Board of the Harbert College of Business at Auburn.

Neb Duric, Ph.D.

Co-Founder and Chief Technology Officer

Dr. Duric, internationally acclaimed leader of innovative scientific research in the field of ultrasound imaging, is the Chief Technology Officer of Delphinus Medical Technologies. An expert in new imaging applications, he is Co-Inventor and developer of ultrasound tomography techniques that have led to the establishment of the Delphinus SoftVue™ imaging system. He is Professor of Oncology at Wayne State University and serves as the Co-Leader of the Molecular Imaging Program at the Karmanos Cancer Institute. He has won a number of awards including Hero of Breast Cancer from Karmanos Cancer Institute, and he has been named Innovator of the Year by the State of Michigan and received a Distinguished Innovator Award from Wayne State University.

Shawn T. O’Brien

Chief Financial Officer

Shawn has served in successively responsible leadership positions throughout his career in finance and accounting. In his role as Chief Financial Officer at Delphinus, he oversees and directs all aspects of fiscal operations, and has piloted unparalleled levels of venture funding, well-distinguished in the medical device industry. His broad-based operational knowledge and experience have directed project management, clinical trial guidance, vendor contracts and partner relationships, while achieving on-time and under-budget successes through cost-sparing strategies and focused implementation. Prior to joining Delphinus, Shawn was head of finance at CytoPherx and Kux Architectural Products, and served as Controller at Advanced Material Process Corporation. Shawn received both his Bachelor of Arts in Accounting and Masters of Business Administration from the University of Michigan, Flint.

Debra Saunders

Vice President of Sales and Marketing

Debra has cultivated a distinguished career in women’s healthcare, with over 20 years at innovative, industry-leading medical imaging companies that have established market-changing firsts in breast cancer detection technologies.  She has developed and led transformational initiatives across an exclusive spectrum of breast imaging platforms.  She built a globally-based professional services division while at Lorad (acquired by Hologic), that became a model of industry best practice in client training for groundbreaking essentials in digital mammography and revolutionary stereotactic breast biopsy guidance systems. During her tenure at R2 Technology, Inc. (acquired by Hologic), she implemented strategic marketing campaigns and exceeded sales projections with double-digit growth, commercializing computer-generated algorithmic analyses of mammographic images to assist physicians with diagnostic interpretation.  She advanced market acceleration of high-resolution molecular breast imaging, utilized for extent-of-disease with breast cancer diagnoses, across diverse markets of radiology, surgery and oncology while at Naviscan, Inc. (acquired by CMR). Debra received her Bachelor of Science, Allied Health, and Master of Science, Health Administration, at The Ohio State University.

Peter J. Littrup, M.D.

Co-Founder and Medical Advisor

Dr. Littrup is a globally-recognized scientist in medical imaging and intervention. He is a board certified radiologist and clinically active breast imager who has conducted extensive research in the domains of cancer screening, ultrasound technology, biopsy guidance, and tumor ablation. As one of the original inventors of ultrasound tomography (UST) and Medical Advisor, he gives Delphinus Medical Technologies his unique full-spectrum experience from screening to biopsy and pioneering breast cryoablation. Dr. Littrup’s vision for the broad use of UST, from screening to treatment follow-up, thereby helped solidify the overall design and testing of the Delphinus SoftVue™ imaging system. He is an Interventional Radiologist at Crittenton Hospital Medical Center, Rochester, Michigan, recruited as Director of the Tumor Ablation Program, and assists in the development of the new breast center with guidance for new technology introduction. He is Professor of Radiology and Oncology at Wayne State University and was principal investigator of the Michigan Translational Research and Commercialization effort of the Michigan Economic Development Corporation. He held the position of full professor in the Department of Diagnostic Imaging at the Warren Alpert Medical School, Brown University, as well as Director of the Human Imaging Core and Ablation Program at Karmanos Cancer Institute. Dr. Littrup Is a graduate of the University of Michigan Medical School, completed a fellowship in prostatic ultrasound at St. Joseph Mercy Hospital in Ann Arbor, Michigan, and was a Radiology Society of North America Research Fellow developing tumor ablation technology and imaging.

Heather Rone

Vice President of Clinical Affairs

Heather is an acknowledged clinical and regulatory professional with a highly successful record of first-ever accomplishments within the medical technology domain. During her nearly seven-year tenure at U-Systems. she was responsible for the development and implementation of a comprehensive global training program for the automated breast ultrasound product line, satisfying new FDA training mandates that became a model for the industry. She directed multiple prospective clinical trials in the U.S. and Europe, enrolling over 18,000 participants. This extraordinary effort and achievement culminated in the first-ever FDA approval for a breast ultrasound screening indication. Among her many firsts, she was instrumental in earning additional regulatory approvals in the U.S. and global markets. Heather has co-authored multiple publications and her research efforts have contributed to several published manuscripts in peer-reviewed journals.

Francis Dobscha

Vice President, Quality Assurance and Regulatory Affairs

Fran comes to Delphinus with extensive experience and leadership in the regulatory affairs and quality systems environment across a broad section of the healthcare industry. Most recently, he served as consultant to large multi-national organizations, tapped for his expertise in complex regulatory systems and approaches.  He served as Vice President of Regulatory in Covidien’s electrosurgery division during the critical period of corporate secession from parent Tyco Corporation, overseeing a cross-functional team that executed far-reaching global initiatives crucial to the new corporate enterprise and identity. During his tenure with AdvaMed directing Technology and Regulatory Affairs, he steered guidance for member corporations, industry representatives, and the trade association while leading interactions with officials from government, academia, professional societies, and advocacy. As Vice President of Quality and Regulatory Affairs at NOMOS Corporation, Fran drove all regulatory and quality programs that were primary to its achievement of becoming a public company through acquisition by North American Scientific. He earned an MBA at the Katz Graduate School of Business, University of Pittsburgh, and his undergraduate degree at Carnegie-Mellon University.

Bruno Dacquay

Vice President of Engineering

Bruno is a passionate entrepreneur and recognized leader in medical device technologies, having had a distinguished career of nearly three decades at Alcon, a division of Novartis.  Driving success in product innovation through to commercialization and market dominance, he earned the executive appointments of Vice President and Franchise Head of Surgical Research and Development, and Vice President of Surgical Instrumentation Research and Development.  During his tenure, he was selected to join top leadership of the organization, the Novartis Corporate Executive Group. Bruno began his career at Biophysic Medical, a French company acquired by Alcon, where he achieved successive promotions with escalating managerial assignments. Retiring from Alcon in 2016, Bruno founded BrighTech Consulting, an organization that guides and assists medical technology companies build technical expertise and maximize product development efficiencies, from concept to launch, to realize organizational excellence. He received his Master’s Degree of Science & Technologies Applied to Biology and Medicine at the University of Lyon, France, with advanced executive leadership education in Breakthrough Process, GAP International, and Program for Management Development, Harvard Business School, Harvard University, Cambridge, Massachusetts.